PRODUCT

°í°´¸¸Á·À» À§ÇØ Áö¼ÓÀûÀ¸·Î °í¹ÎÇϰí Çõ½ÅÇÏ¿© ÃÖ°íÀÇ Ç°ÁúÀ» Á¦°øÇÕ´Ï´Ù.

R&D reagents

Product > R&D reagents
Neostigmine methyl sulfate, 98%
CAS No O811-1g
Á¦Ç°¹øÈ£ AK Sci.(USA)
Á¦Á¶»ç ¼öÀÔ»ê
Àç°í 1 EA
±Ý¾× 67,000¿ø
Æ÷Àå´ÜÀ§
Æ÷Àå´ÜÀ§



3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium methyl sulfate
(3-Hydroxyphenyl)trimethylammonium Methyl Sulfate Dimethylcarbamate




¡Ø È­Çиí : Neostigmine methyl sulfate, 98%

 

¡Ø µî±Þ : APIs and Bioactives > AChR Agonists

 

¡Ø ÆÇ¸Å Æ÷Àå´ÜÀ§ : 1g , 5g , 25g

 

¡Ø È­ÇÐ½Ä : MFCD00011796

 

¡Ø CAS # : [51-60-5]

IDENTITY
CAS Registry #: [51-60-5]
MDL Number: MFCD00011796
MF: C13H22N2O6S
MW: 334.39
SPECIFICATIONS & PROPERTIES
Purity: 98%
Available Spectra:

 

NMR, LCMS

Physical Form: White crystalline powder
Melting Point: 146-148¡ÆC

Long-Term Storage:

 

Store long-term at 2-8¡ÆC

Shipping: Regulated for Shipping
UN #: 2811
Hazard Class: 6.1
Packing Group: II

BIOLOGICAL INFO
Application(s): Cholinesterase inhibitor

REVIEW

Neostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor. The drug inhibits acetylcholinesterase which is responsible for the degredation of acetylcholine. So, with acetylcholinesterase inhibited, more acetylcholine is present By interfering with the breakdown of acetylcholine, neostigmine indirectly stimulates both nicotinic and muscarinic receptors which are involved in muscle contraction.. It does not cross the blood-brain barrier.

Risk Description(s)
R36/37/38: Irritating to eyes, respiratory system and skin

Safety Description(s)
S24/25: Avoid contact with skin and eyes.